Literature DB >> 10353114

[Hypertension-related mortality and arterial pressure in Spain].

J R Banegas Banegas1, F Rodríguez-Artalejo, J J de la Cruz Troca, B de Andrés Manzano, J del Rey Calero.   

Abstract

BACKGROUND: Given the high figures of cardiovascular disease and hypertension in Spain, and the continuity of cardiovascular and total mortality risks at any level of blood pressure, mortality related to hypertension and blood pressure is estimated. SUBJECTS AND METHODS: Blood pressure distribution from a representative sample of the 35 to 64 years old Spanish population and the relative risks for death coming from valid and reasonably generalizable international studies (MRFIT, Framingham and Chicago Project) were used. The proportions and absolute numbers of cardiovascular and total deaths related to blood pressure and hypertension (categories of the US Joint National Committee VI [JNC VI]) have been calculated in middle-aged men and women.
RESULTS: As many as 42% of the coronary deaths, 46.4% of the stroke deaths and 25.5% of the total deaths are related to hypertension (> or = 140/90 mmHg), most of them in stages 1 and 2. It follows high-normal plus normal blood pressure group (8.3, 10.2 and 6.2% of these deaths, respectively). All together, 17,266 total deaths and 4,502 cardiovascular deaths related to blood pressure took place annually, three-quarters of them in males. Over the last ones, 65.5% are coronary and 34.5% cerebrovascular, prevailing the first ones in both sexes. Eight out of 10 deaths, cardiovascular or total, related to blood pressure are concentrated in the hypertension categories, and two out of 10 in the high-normal or normal blood pressure groups.
CONCLUSIONS: One out of 3 total deaths and one out of 2 cardiovascular deaths are related to blood pressure. One out of 4 total deaths and one out of 2.5 cardiovascular deaths are related to hypertension. A substantial part of these deaths come from stages 1 and 2 hypertension and from high-normal and normal blood pressure group.

Entities:  

Mesh:

Year:  1999        PMID: 10353114

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  5 in total

1.  [Can or should blood pressure be measured at pharmacy offices?].

Authors:  J Divisón; L Artigao; C Sanchis; F Alvarez; J Carbayo; L Carrión; E Martínez-Navarro
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

2.  [Current situation of hypertensive patients over 75 years old: the DISEHTAE study].

Authors:  Antonio Martínez Pastor; Mariano Leal Hernández; Luis Alberto Vara González; Luis Javier González Elena; Eduardo Paja Fano; Juan López Abril
Journal:  Aten Primaria       Date:  2008-05       Impact factor: 1.137

3.  [Degree of understanding, treatment and control of hypertension, hypercholesterolemia and diabetes mellitus in the general adult population].

Authors:  M Pineda Cuenca; J Custardoy Olavarrieta; J M Ortín Arróniz; J G Cano Montoro; M T Andreu Ruiz; C Grau
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

4.  Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients.

Authors:  Manuel A Gómez-Marcos; Carlos Martínez-Salgado; Carlos Martin-Cantera; José I Recio-Rodríguez; Yolanda Castaño-Sánchez; Maria Giné-Garriga; Emiliano Rodriguez-Sanchez; Luis García-Ortiz
Journal:  BMC Cardiovasc Disord       Date:  2009-05-11       Impact factor: 2.298

Review 5.  Methodologies used to estimate tobacco-attributable mortality: a review.

Authors:  Mónica Pérez-Ríos; Agustín Montes
Journal:  BMC Public Health       Date:  2008-01-22       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.